MMP9 and Stroke: Serial IL-6, TNF-<i>α</i>, IL-1β, MMP-9, C-reactive protein, and neutrophil-to-lymphocyte ratio were measured to 72 h; reperfusion quality, final infarct volume, infarct progression, NIHSS change, and 90-day modified Rankin Scale (mRS) were compared.<h4>Results</h4>Baseline demographics, risk factors, stroke severity, and inflammatory profiles were similar across groups.